CN105343336A - 一种消糖灵胶囊及其制备方法 - Google Patents
一种消糖灵胶囊及其制备方法 Download PDFInfo
- Publication number
- CN105343336A CN105343336A CN201510905122.XA CN201510905122A CN105343336A CN 105343336 A CN105343336 A CN 105343336A CN 201510905122 A CN201510905122 A CN 201510905122A CN 105343336 A CN105343336 A CN 105343336A
- Authority
- CN
- China
- Prior art keywords
- carbon dioxide
- dry
- ground
- radix
- extracting solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种消糖灵胶囊及其制备方法,其特征在于取沉香192g,茯苓96g,火麻仁19.2g,黄连30g,天花粉490g,杜仲88g,黄芪512g,丹参180g,枸杞子128g,沙苑子160g,采用二氧化碳超临界萃取法提取,减压干燥,用高能纳米冲击磨粉碎成纳米干膏,加入功能性辅料,制成消糖灵胶囊,崩解时间显著缩短,疗效显著优于市售消糖灵胶囊,取得了积极效果。
Description
技术领域
本发明涉及中药领域,具体涉及一种消糖灵胶囊及其制备方法。
背景技术
消糖灵胶囊益气养阴,清热泻火,益肾缩尿。用于糖尿病。市售消糖灵胶囊由于组方和工艺原因,疗效不甚理想,制剂采用传统工艺制备,存在崩解迟缓、疗效低等不足。
发明内容
本发明为克服上述不足,提供一种崩解速度快、疗效高的消糖灵胶囊及其制备方法。
发明实施方案如下:
取沉香192g,茯苓96g,火麻仁19.2g,黄连30g,天花粉490g,杜仲88g,黄芪512g,丹参180g,枸杞子128g,沙苑子160g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力24~35Mpa,萃取温度16~43℃,分离器压力11~19Mpa,分离器温度42~58℃,分离时间1.7~3.3小时,二氧化碳流量每小时26~33L,得提取液;取提取液62~78℃减压干燥,得干膏;取干膏加入甘露醇150~200g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素45~55g,交联聚乙烯吡咯烷酮45~55g,交联羧甲基纤维素钠35~45g,混合均匀,用50~70%乙醇湿法制粒,60℃~80℃干燥,外加羧甲基淀粉钠7~9g,硬脂酸镁1~3g,整粒,装入胶囊,制得消糖灵胶囊1000粒。
上述实施方案所提到的原材料标准如下:
沉香:中国药典2005年版一部标准。本品为瑞香料植物白木香Aquilariasinensis(Lour.)Gilg含有树脂的木材。全年均可采收,割取含树脂的木材.除去不含树脂的部分,阴干。
茯苓:中国药典2005年版一部标准。本品为多孔菌科真菌茯苓Poriacocos(Schw.)Wolf的干燥菌核。多于7-9月采挖,挖出后除去泥沙,堆置“发汗”后,摊开晾至表面干燥,再“发汗”,反复数次至现皱纹、内部水分大部散失后,阴干,称为“茯苓个”;或将鲜茯苓按不同部位切制,阴于,分别称为“茯苓皮”及“茯苓块”。
火麻仁:中国药典2005年版一部标准。本品为桑科植物大麻CannabissativaL.的干燥成熟果实。秋季果实成熟时采收,除去杂质,晒干。
黄连:中国药典2005年版一部标准。本品为毛茛科植物黄连CoplischinensisFranch.、三角叶黄连CoptisdeltoideaC.Y.ChengetHsiao或云连CoptisteetaWall.的干燥根茎。以上三种分别习称“味连”、“雅连”、“云连”。秋季来挖,除去须根及泥沙,干燥,撞去残留须根。
天花粉:中国药典2005年版一部标准。本品为葫芦科植物栝楼TrichosantheskirilowiiMaxim.或双边栝楼TrichosanthesrosthorniiHarms的干燥根。秋、冬二季采挖,洗净,除去外皮,切段或纵剖成瓣,干燥。
杜仲:中国药典2005年版一部标准。本品为杜仲科植物杜仲EucommiaulmoidesOliv.的干燥树皮。4-6月剥取,刮去粗皮,堆置“发汗”至内皮呈紫褐色,晒干。
黄芪:中国药典2005年版一部标准。本品为豆科植物蒙古黄芪Astragalusmembranaceus(Fisch.)Bge.var.mongholicus(Bge.)Hsiao或膜荚黄芪Astragalusmembranaceus(Fisch.)Bge,的干燥根。春、秋二李采挖,除去须根及根头,晒干。
丹参:中国药典2005年版一部标准。本品为唇形科植物丹参SalviamiltiorrhizaBge.的干燥根及根茎。春、秋二季采挖,除去泥沙,干燥。
枸杞子:中国药典2005年版一部标准。本品为茄科植物宁夏枸杞LyciumbarbarumL.的干燥成熟果实。夏、秋二季果实呈红色时采收,热风烘干,除去果梗,或晾至皮皱后,晒干,除去果梗。
沙苑子:中国药典2005年版一部标准。本品为豆科植物扁茎黄芪AstragaluscomplanatusR.Br.的干燥成熟种子。秋末冬初果实成熟尚未开裂时采割植株,晒干,打下种子,除去杂质,晒干。
甘露醇:中国药典2010年版二部标准。
微晶纤维素:中国药典2010年版二部标准。
交联聚乙烯吡咯烷酮:中国药典2010年版二部标准。
交联羧甲基纤维素钠:中国药典2010年版二部标准。
羧甲基淀粉钠:中国药典2010年版二部标准。
硬脂酸镁:中国药典2010年版二部标准。
以上消糖灵胶囊所用到的原材料均可从医药公司购买得到,只要满足国家标准均可用来实施本发明方案。
上述发明方案中所用术语为药学专用术语,如“减压”等皆遵从中国药典规定和相关药学规范。
本发明中的单位g也可以是其它重量份,不影响本发明方案的实施。
本发明方案中所述的设备市场均有销售,并不限于典型生产厂家,只要技术指标能够达到要求,均可用来实现本发明。
四具体实施方式
本发明的具体实施例1
取沉香192g,茯苓96g,火麻仁19.2g,黄连30g,天花粉490g,杜仲88g,黄芪512g,丹参180g,枸杞子128g,沙苑子160g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力24Mpa,萃取温度16℃,分离器压力11Mpa,分离器温度42℃,分离时间1.7小时,二氧化碳流量每小时26L,得提取液;取提取液62℃减压干燥,得干膏;取干膏加入甘露醇150g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素45g,交联聚乙烯吡咯烷酮45g,交联羧甲基纤维素钠35g,混合均匀,用50%乙醇湿法制粒,60℃干燥,外加羧甲基淀粉钠7g,硬脂酸镁1g,整粒,装入胶囊,制得消糖灵胶囊1000粒。
本发明的具体实施例2
取沉香192g,茯苓96g,火麻仁19.2g,黄连30g,天花粉490g,杜仲88g,黄芪512g,丹参180g,枸杞子128g,沙苑子160g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力35Mpa,萃取温度43℃,分离器压力19Mpa,分离器温度58℃,分离时间3.3小时,二氧化碳流量每小时33L,得提取液;取提取液78℃减压干燥,得干膏;取干膏加入甘露醇200g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素55g,交联聚乙烯吡咯烷酮55g,交联羧甲基纤维素钠45g,混合均匀,用70%乙醇湿法制粒,80℃干燥,外加羧甲基淀粉钠9g,硬脂酸镁3g,整粒,装入胶囊,制得消糖灵胶囊1000粒。
本发明的具体实施例3
取沉香192g,茯苓96g,火麻仁19.2g,黄连30g,天花粉490g,杜仲88g,黄芪512g,丹参180g,枸杞子128g,沙苑子160g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力30Mpa,萃取温度30℃,分离器压力15Mpa,分离器温度50℃,分离时间2.5小时,二氧化碳流量每小时30L,得提取液;取提取液70℃减压干燥,得干膏;取干膏加入甘露醇175g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素50g,交联聚乙烯吡咯烷酮50g,交联羧甲基纤维素钠40g,混合均匀,用60%乙醇湿法制粒,70℃干燥,外加羧甲基淀粉钠8g,硬脂酸镁2g,整粒,装入胶囊,制得消糖灵胶囊1000粒。
以上实施例说明,采用本发明实施方案的极端条件和优化条件均能制成消糖灵胶囊。下面以实施例3制得的消糖灵胶囊考察本发明的实际效果:
(一)实施例3消糖灵胶囊和市售消糖灵胶囊崩解时限对比
1崩解时限测定方法
按中国药典2010年版附录ⅫA测定。
2崩解时限对比
表1实施例3消糖灵胶囊和市售消糖灵胶囊崩解时限对比表
上述结果表明,本发明制备的消糖灵胶囊相对于市售消糖灵胶囊具有崩解速度快、生物利用度高等显著优点。
(二)实施例3消糖灵胶囊和市售消糖灵胶囊治疗糖尿病临床疗效观察
1病例情况
统计门诊和住院病例,共观察糖尿病病例134例,平均年龄57岁。将患者分为两组,试验组服用实施例3消糖灵胶囊,对照组服用市售消糖灵胶囊。
2疗效评定标准
依据中药新药治疗临床研究指导原则中医证候疗效判定标准:
临床痊愈:中医临床症状、体征消失或基本消失,证候积分减少≥95%。
显效:中医临床症状、体征明显改善,证候积分减少≥70%。
有效:中医临床症状、体征均有好转,证候积分减少≥30%。
无效:中医临床症状、体征均均无明显改善或者加重,证候积分减少<30%。
计算公式:[(治疗前积分-治疗后积分)÷治疗前积分]×100%。
3临床观察结果
表2实施例3消糖灵胶囊和市售消糖灵胶囊临床疗效对比表
上述临床疗效观察结果表明,本发明制备的消糖灵胶囊在治疗糖尿病时,疗效显著高于市售消糖灵胶囊,p<0.05。
Claims (3)
1.一种治疗糖尿病的中药,其特征是取沉香192g,茯苓96g,火麻仁19.2g,黄连30g,天花粉490g,杜仲88g,黄芪512g,丹参180g,枸杞子128g,沙苑子160g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力24~35Mpa,萃取温度16~43℃,分离器压力11~19Mpa,分离器温度42~58℃,分离时间1.7~3.3小时,二氧化碳流量每小时26~33L,得提取液;取提取液62~78℃减压干燥,得干膏;取干膏加入甘露醇150~200g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素45~55g,交联聚乙烯吡咯烷酮45~55g,交联羧甲基纤维素钠35~45g,混合均匀,用50~70%乙醇湿法制粒,60℃~80℃干燥,外加羧甲基淀粉钠7~9g,硬脂酸镁1~3g,整粒,装入胶囊,制得消糖灵胶囊。
2.根据权利要求1所述中药的制备方法,其特征是取沉香192g,茯苓96g,火麻仁19.2g,黄连30g,天花粉490g,杜仲88g,黄芪512g,丹参180g,枸杞子128g,沙苑子160g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力24~35Mpa,萃取温度16~43℃,分离器压力11~19Mpa,分离器温度42~58℃,分离时间1.7~3.3小时,二氧化碳流量每小时26~33L,得提取液;取提取液62~78℃减压干燥,得干膏;取干膏加入甘露醇150~200g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素45~55g,交联聚乙烯吡咯烷酮45~55g,交联羧甲基纤维素钠35~45g,混合均匀,用50~70%乙醇湿法制粒,60℃~80℃干燥,外加羧甲基淀粉钠7~9g,硬脂酸镁1~3g,整粒,装入胶囊,制得消糖灵胶囊。
3.根据权利要求1所述中药的制备方法,取沉香192g,茯苓96g,火麻仁19.2g,黄连30g,天花粉490g,杜仲88g,黄芪512g,丹参180g,枸杞子128g,沙苑子160g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力30Mpa,萃取温度30℃,分离器压力15Mpa,分离器温度50℃,分离时间2.5小时,二氧化碳流量每小时30L,得提取液;取提取液70℃减压干燥,得干膏;取干膏加入甘露醇175g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素50g,交联聚乙烯吡咯烷酮50g,交联羧甲基纤维素钠40g,混合均匀,用60%乙醇湿法制粒,70℃干燥,外加羧甲基淀粉钠8g,硬脂酸镁2g,整粒,装入胶囊,制得消糖灵胶囊。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510905122.XA CN105343336A (zh) | 2015-12-10 | 2015-12-10 | 一种消糖灵胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510905122.XA CN105343336A (zh) | 2015-12-10 | 2015-12-10 | 一种消糖灵胶囊及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105343336A true CN105343336A (zh) | 2016-02-24 |
Family
ID=55319494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510905122.XA Pending CN105343336A (zh) | 2015-12-10 | 2015-12-10 | 一种消糖灵胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105343336A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111759963A (zh) * | 2020-06-15 | 2020-10-13 | 孙晓宣 | 一种治疗糖尿病的代餐粉及其制备方法 |
-
2015
- 2015-12-10 CN CN201510905122.XA patent/CN105343336A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111759963A (zh) * | 2020-06-15 | 2020-10-13 | 孙晓宣 | 一种治疗糖尿病的代餐粉及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104491304A (zh) | 一种妇科止带片及其制备方法 | |
CN105343336A (zh) | 一种消糖灵胶囊及其制备方法 | |
CN105456763A (zh) | 一种肾康宁胶囊及其制备方法 | |
CN105343681A (zh) | 一种止咳橘红胶囊及其制备方法 | |
CN104225359A (zh) | 一种降糖甲片及其制备方法 | |
CN105412028A (zh) | 一种降脂灵片及其制备方法 | |
CN105456700A (zh) | 一种益肾补骨胶囊及其制备方法 | |
CN104474384A (zh) | 一种复肝宁片及其制备方法 | |
CN105343676A (zh) | 一种清热解毒片及其制备方法 | |
CN104398935A (zh) | 一种化痔片及其制备方法 | |
CN105343509A (zh) | 一种玉泉胶囊及其制备方法 | |
CN105434977A (zh) | 一种藿香正气胶囊及其制备方法 | |
CN104398951A (zh) | 一种胃痛定片及其制备方法 | |
CN105327048A (zh) | 一种屏风生脉胶囊及其制备方法 | |
CN105343573A (zh) | 一种益肺胶囊及其制备方法 | |
CN105726924A (zh) | 消渴灵片及其制备方法 | |
CN105412748A (zh) | 一种抗痨胶囊及其制备方法 | |
CN105412753A (zh) | 一种净石灵胶囊及其制备方法 | |
CN105412408A (zh) | 一种甘露消渴胶囊及其制备方法 | |
CN105412694A (zh) | 一种抗饥消渴片及其制备方法 | |
CN105343429A (zh) | 一种杞菊地黄胶囊及其制备方法 | |
CN105343677A (zh) | 一种消栓通络胶囊及其制备方法 | |
CN105343730A (zh) | 一种溃疡灵胶囊及其制备方法 | |
CN105412457A (zh) | 一种治偏痛胶囊及其制备方法 | |
CN105343396A (zh) | 一种桂芍镇痫片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160224 |
|
WD01 | Invention patent application deemed withdrawn after publication |